PERSONALIZED MANAGEMENT OF PEDIATRIC ATOPIC DERMATITIS BASED ON MOLECULAR ALLERGY DIAGNOSTICS: A REVIEW
Abstract
Background. Atopic dermatitis is one of the most common chronic inflammatory skin diseases in children, characterized by early onset, recurrent course, and significant impairment of quality of life. The heterogeneity of clinical phenotypes, immunological endotypes, and allergen sensitization patterns complicates diagnosis and treatment. Recent advances in molecular allergy diagnostics and precision medicine have enabled identification of individual sensitization profiles and development of personalized treatment strategies. However, available data on personalized management of pediatric atopic dermatitis remain fragmented and require comprehensive analysis.
References
1. Асадова Д.Ш., Каримов Б.Ш. Персонализированный подход к терапии атопического дерматита у детей в Республике Узбекистан // Здравоохранение Узбекистана. – 2023. – №2. – С. 51–58.
2. Каримов Б.Ш., Хамраев Н.У. Клинико-иммунологическая эффективность биологических препаратов у пациентов с тяжелым атопическим дерматитом // Вестник ТГМУ. – 2024. – №3. – С. 48–55.
3. Разикова Г.Р. Эффективность персонализированного алгоритма лечения пациентов с атопическим дерматитом//Мед.журнал Узбекистана.-2025, №6, стр.95-100
4. Разикова И. С., Разикова Г. Р. Совершенствование аллергологической службы узбекистана //Аллергическое и иммунопатологические заболевания-проблема XXI века. – 2019. – С. 23-24.
5. Разикова И. С. и др. Распространенность полиморфизмов RS1800925, RS20541 гена IL13 при атопическом синдроме в республике Узбекистан //E-Conference platform. – 2025. – Т. 1. – №. 17-noyabr 2025. – С. 213-213.
6. Разикова И. С., Айдарова Н. П., Ишмухамедова Ш. Б. Дерматореспираторный синдром и атопический марш: диагностика, клиника //Central Asian Journal of Medical and Natural Science. – 2023. – Т. 4. – №. 6. – С. 37-41.
7. Разикова И. С. и др. Оценка динамики различных методов лечения при респираторных аллергозах //Первичные иммунодефициты и COVID-19. – 2023. – С. 84-91.
8. Agache I., Akdis C.A. Precision medicine in allergy // Allergy. — 2022. — Vol. 77(2). — P. 340–356.
9. Akdis C.A., Arkwright P.D., Bruggen M.C. Type 2 immunity in atopic dermatitis // Journal of Allergy and Clinical Immunology. — 2020. — Vol. 145(1). — P. 1–20.
10. Arkwright P.D., Motala C., Subramanian H. Pediatric allergy management // Allergy. — 2020. — Vol. 75(5). — P. 1025–1035.
11. Beck L.A., Thaci D., Hamilton J.D. Biomarkers in atopic dermatitis // Journal of Allergy and Clinical Immunology. — 2018. — Vol. 142(5). — P. 1406–1413.
12. Bieber T. Atopic dermatitis: new treatment approaches // Nature Reviews Drug Discovery. — 2022. — Vol. 21. — P. 21–40.
13. Boguniewicz M., Leung D.Y.M. Atopic dermatitis: treatment approaches // Journal of Allergy and Clinical Immunology. — 2018. — Vol. 142(4). — P. 1085–1095.
14. Canonica G.W., Ansotegui I.J., Pawankar R. et al. WAO guidelines for allergy management // World Allergy Organization Journal. — 2020. — Vol. 13. — P. 100091.
15. D'Erme A.M., Wilsmann-Theis D., Bieber T. Clinical phenotypes of atopic dermatitis // Allergy. — 2022. — Vol. 77(2). — P. 339–351.
16. Guttman-Yassky E., Bissonnette R., Ungar B. New therapies in atopic dermatitis // Journal of Allergy and Clinical Immunology. — 2023. — Vol. 151(2). — P. 299–308.
17. Hamilton R.G., Oppenheimer J. Serological IgE analyses in allergic disease // Journal of Allergy and Clinical Immunology Practice. — 2018. — Vol. 6(5). — P. 1467–1476.
18. Howell M.D., Kim B.E., Gao P. Skin barrier dysfunction in atopic dermatitis // Journal of Allergy and Clinical Immunology. — 2017. — Vol. 139(4). — P. 45–52.
19. Irvine A.D., McLean W.H. Filaggrin mutations in atopic dermatitis // New England Journal of Medicine. — 2020. — Vol. 383. — P. 1387–1395.
20. Kabashima K. New insights into atopic dermatitis pathogenesis // Nature Reviews Immunology. — 2021. — Vol. 21. — P. 356–369.
21. Langan S.M., Irvine A.D., Weidinger S. Atopic dermatitis // Lancet. — 2020. — Vol. 396. — P. 345–360.
22. Matricardi P.M., Kleine-Tebbe J., Hoffmann H.J. et al. Molecular allergology user's guide // Pediatric Allergy and Immunology. — 2016. — Vol. 27(Suppl. 23). — P. 1–250.
23. Nomura I., Gao B., Boguniewicz M. Cytokine biomarkers in atopic dermatitis // Journal of Allergy and Clinical Immunology. — 2018. — Vol. 142(4). — P. 1023–1031.
24. Paller A.S., Kabashima K., Bieber T. Therapeutic pipeline for atopic dermatitis // Journal of Allergy and Clinical Immunology. — 2021. — Vol. 148(1). — P. 72–83.
25. Paller A.S., Simpson E.L., Siegfried E. Pediatric atopic dermatitis management // Journal of Allergy and Clinical Immunology Practice. — 2023. — Vol. 11(3). — P. 589–598.
26. Silverberg J.I. Epidemiology of atopic dermatitis // Dermatologic Clinics. — 2022. — Vol. 40(3). — P. 247–258.
27. Simpson E.L. Atopic dermatitis: update on treatment // Journal of Allergy and Clinical Immunology. — 2020. — Vol. 145(1). — P. 1–20.
28. Spergel J.M. Pediatric allergy and atopic dermatitis // Journal of Allergy and Clinical Immunology. — 2020. — Vol. 145(2). — P. 455–461.
29. Thyssen J.P. Environmental risk factors in atopic dermatitis // Journal of Allergy and Clinical Immunology. — 2021. — Vol. 147(2). — P. 345–356.
30. Valenta R., Duchene M., Vrtala S. Component-resolved diagnostics in allergy // Allergy. — 2020. — Vol. 75(12). — P. 3026–3038.
31. Weidinger S., Novak N. Atopic dermatitis // Lancet. — 2016. — Vol. 387(10023). — P. 1109–1122.
32. Wollenberg A., Barbarot S., Bieber T. et al. Consensus-based European guidelines for treatment of atopic eczema // Journal of the European Academy of Dermatology and Venereology. — 2018. — Vol. 32(5). — P. 657–682.
